| Gene ID |
Gene Name |
Sequence Strain (Species/Organism) |
VO ID |
NCBI Gene ID |
NCBI Nucleotide GI |
NCBI Protein GI |
Locus Tag |
Genbank Accession |
Protein Accession |
3D structure: PDB ID |
Other Database IDs |
Protein Name |
Molecule Role |
Vaccines Involving this Gene |
|
4632
|
7299 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4527
|
AAV2gp02 |
Adeno-associated virus - 2 |
|
1489608
|
|
110645918
|
AAV2gp02 |
AF043303 |
YP_680423 |
|
|
Rep 78 protein |
Protective antigen |
|
|
4672
|
ABALON |
Homo sapiens |
|
103021294
|
|
|
|
AL160175 |
|
|
|
apoptotic BCL2L1-antisense long non-coding RNA |
Protective antigen |
|
|
4460
|
ABL2 |
Homo sapiens |
|
27
|
|
209862772
|
|
AL139132 |
NP_001129472 |
|
|
transcript variant X4 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
|
|
4562
|
ACP3 |
Homo sapiens |
|
55
|
|
6382064
|
|
AC020633 |
NP_001090 |
|
|
transcript variant X2 |
Protective antigen |
MVA-PSA/PAP Prostate Cancer Vaccine
Sipuleucel-T Vaccine
|
|
702
|
ACPP |
Homo sapiens |
|
55
|
|
6382064
|
|
AC020633 |
NP_001090 |
1CVI
|
|
transcript variant 2 |
Protective antigen |
PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
APC8015F
|
|
4459
|
ADAM17 |
Homo sapiens |
|
6868
|
|
1843978386
|
|
AB034151 |
NP_001369706 |
|
|
transcript variant 1 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
IMT-1012 Immunotherapeutic Vaccine
|
|
315
|
AFP |
Homo sapiens |
|
174
|
|
4501989
|
|
AC108157 |
NP_001125 |
|
|
transcript variant 1 |
Protective antigen |
Alpha Fetoprotein Plasmid DNA Vaccine
AFP Gene Hepatocellular Carcinoma Vaccine
Alpha Fetoprotein Adenoviral Vector Vaccine
Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
Cytokine-Induced Killer Cells
Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
|
|
3822
|
AFP from human-Obsolete |
Homo sapiens |
|
174
|
|
4501989
|
|
AC108157 |
NP_001125 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4464
|
ag85A |
Mycobacterium tuberculosis H37Rv |
|
23489907
|
|
489997754
|
RVBD_RS20065 |
AL123456 |
WP_003900759 |
|
|
diacylglycerol acyltransferase/mycolyltransferase Ag85A |
Protective antigen |
TICE BCG
|
|
4451
|
AIM2 |
Homo sapiens |
|
9447
|
|
1134787082
|
|
AL035403 |
NP_001335176 |
|
|
transcript variant X2 |
Protective antigen |
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
|
|
4763
|
AKAP4 |
Homo sapiens |
|
8852
|
|
21493037
|
|
AC235789 |
NP_003877 |
|
|
transcript variant 1 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
4601
|
AKT1 |
Homo sapiens |
|
207
|
|
62241013
|
|
A62733 |
NP_001014431 |
|
|
transcript variant X1 |
Protective antigen |
RCAS-Akt Vaccine
|
|
4678
|
ALDH1A1 |
Homo sapiens |
|
216
|
|
21361176
|
|
AH002598 |
NP_000680 |
|
|
aldehyde dehydrogenase 1 family member A1 |
Protective antigen |
Autologous Pluripotent ALDHbr Stem Cells ALD-451
Allogeneic Melanoma Vaccine AGI-101H
|
|
4679
|
ALDH2 |
Homo sapiens |
|
217
|
|
25777732
|
|
AC002996 |
NP_000681 |
|
|
transcript variant 1 |
Protective antigen |
Autologous Pluripotent ALDHbr Stem Cells ALD-451
|
|
300
|
ANTXR1 |
Homo sapiens |
|
84168
|
|
16933553
|
|
AC112230 |
NP_060623 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4724
|
AR |
Homo sapiens |
|
367
|
|
21322252
|
|
AF159087 |
NP_000035 |
|
|
transcript variant 1 |
Protective antigen |
Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
|
|
4940
|
asdfaf asf |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4735
|
ASTE1 |
Homo sapiens |
|
28990
|
|
572881924
|
|
AC055733 |
NP_001275879 |
|
|
transcript variant 3 |
Protective antigen |
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
|
|
4665
|
ATL1 |
Homo sapiens |
|
51062
|
|
189181742
|
|
AL118556 |
NP_001121185 |
|
|
transcript variant 3 |
Protective antigen |
Dendritic Cell Tumor Cell Lysate Vaccine
|
|
4546
|
B4GALNT1 |
Homo sapiens |
|
2583
|
|
451172101
|
|
AC025165 |
NP_001263397 |
|
|
transcript variant X4 |
Protective antigen |
Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
|
|
4457
|
BCAP31 |
Homo sapiens |
|
10134
|
|
213511012
|
|
CH471172 |
NP_001132913 |
|
|
transcript variant X2 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
|
|
4671
|
BCL2L1 |
Homo sapiens |
|
598
|
|
4502381
|
|
AL117381 |
NP_001182 |
|
|
transcript variant 6 |
Protective antigen |
Bcl-Xs Adenovirus Vaccine
|
|
4550
|
CA9 |
Homo sapiens |
|
768
|
|
169636420
|
|
AL133410 |
NP_001207 |
|
|
transcript variant X2 |
Protective antigen |
mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
|
|
4691
|
CCL21 |
Homo sapiens |
|
6366
|
|
4506835
|
|
AF030572 |
NP_002980 |
|
|
C-C motif chemokine ligand 21 |
Protective antigen |
Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
|
|
1390
|
Ccl21a |
Mus musculus |
|
18829
|
|
14547891
|
RP23-411B7.4 |
AF035684 |
NP_035254 |
|
|
chemokine (C-C motif) ligand 21A (serine) |
Protective antigen |
|
|
4948
|
CCNG1 |
Homo sapiens |
|
900
|
|
1395168480
|
|
AC112205 |
NP_001350944 |
|
|
transcript variant X3 |
Protective antigen |
Retrovector Encoding Mutant Anti-Cyclin G1 Vaccine
|
|
4495
|
CCNI |
Homo sapiens |
|
10983
|
|
1130413436
|
|
AC104771 |
NP_001335061 |
|
|
transcript variant 1 |
Protective antigen |
IMT-1012 Immunotherapeutic Vaccine
|
|
4540
|
CCR5 |
Homo sapiens |
|
1234
|
|
4502639
|
|
AB182982 |
NP_000570 |
|
|
transcript variant A |
Protective antigen |
Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
|
|
4718
|
CCR7 |
Homo sapiens |
|
1236
|
|
683523912
|
|
AC004585 |
NP_001288643 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4723
|
CD19 |
Homo sapiens |
|
930
|
|
296010921
|
|
AB052799 |
NP_001171569 |
|
|
transcript variant X3 |
Protective antigen |
|
|
4714
|
CD1D |
Homo sapiens |
|
912
|
|
982742445
|
|
AF142668 |
NP_001306074 |
|
|
transcript variant X3 |
Protective antigen |
|
|
4642
|
CD22 |
Homo sapiens |
|
933
|
|
297374825
|
|
AB012995 |
NP_001172028 |
|
|
transcript variant 4 |
Protective antigen |
EF-2 Peptide Vaccine
|
|
4738
|
CD33 |
Homo sapiens |
|
945
|
|
130980072
|
|
AC063977 |
NP_001076087 |
|
|
transcript variant X2 |
Protective antigen |
Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
|
|
4693
|
CD38 |
Homo sapiens |
|
952
|
|
38454326
|
|
AC005798 |
NP_001766 |
|
|
transcript variant 2 |
Protective antigen |
Autologous Dendritic Cell-Tumor Fusion Vaccine
|
|
4733
|
CD3D |
Homo sapiens |
|
915
|
|
4502669
|
|
AH002612 |
NP_000723 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4446
|
CD40 |
Homo sapiens |
|
958
|
|
4507581
|
|
AL035662 |
NP_001241 |
|
|
transcript variant 7 |
Protective antigen |
Adenovirus 5-CD40 Ligand
Prostate Cancer Vaccine ONY-P1
Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
Autologous Dendritic Cell Vaccine ACT2001
Cancer DNA Vaccine pSURV encoding Survivin
|
|
305
|
Cd40lg |
Mus musculus |
|
21947
|
|
15011846
|
RP23-153G22.3 |
AH006031 |
NP_035746 |
|
|
CD40 ligand |
Protective antigen |
Cancer Retroviral Vector Vaccine encoding Cd40lg
|
|
4698
|
CD40LG |
Homo sapiens |
|
959
|
|
4557433
|
|
AB897731 |
NP_000065 |
|
|
CD40 ligand |
Protective antigen |
Ad-sig-hMUC-1/ecdCD40L Vaccine
Autologous Ad-CD154-Transduced CLL B Cells
Allogeneic Renal Cell Carcinoma Vaccine MGN1601
Autologous CD40L-expressing B-CLL Vaccine
Autologous TriMix-DC Melanoma Vaccine
|
|
4734
|
CD44 |
Homo sapiens |
|
960
|
|
48255935
|
|
AB462491 |
NP_000601 |
|
|
transcript variant X1 |
Protective antigen |
|
|
4542
|
CD55 |
Homo sapiens |
|
1604
|
|
10835143
|
|
AB003312 |
NP_000565 |
|
|
transcript variant 8 |
Protective antigen |
Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
|
|
4613
|
CD58 |
Homo sapiens |
|
965
|
|
221316575
|
|
AL355794 |
NP_001138294 |
|
|
transcript variant 3 |
Protective antigen |
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Fowlpox-TRICOM Vaccine
Rilimogene-galvacirepvec Vaccine
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
Brain Tumor Initiating Cell Vaccine
|
|
4748
|
CD70 |
Homo sapiens |
|
970
|
|
4507605
|
|
AC008760 |
NP_001243 |
|
|
transcript variant 2 |
Protective antigen |
Autologous TriMix-DC Melanoma Vaccine
|
|
311
|
Cd80 |
Mus musculus |
|
12519
|
|
1331037341
|
|
AC154425 |
NP_001346827 |
|
|
transcript variant X1 |
Protective antigen |
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Fowlpox-TRICOM Vaccine
Recombinant Vaccinia-MUC1-B7 Vaccine
Rilimogene-galvacirepvec Vaccine
Autologous IL-2-expressing B-CLL Vaccine
|
|
4702
|
CD80 |
Homo sapiens |
|
941
|
|
4885123
|
|
AB033124 |
NP_005182 |
|
|
CD80 molecule |
Protective antigen |
Adenovirus B7-1
Allogeneic Renal Cell Carcinoma Vaccine MGN1601
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
ALVAC-B7-CEA
ALVAC-CEA (6D)-B7.1 Vaccine
Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
CD80 Breast Cancer Vaccine
ALVAC-CEA B7.1 Vaccine
Brain Tumor Initiating Cell Vaccine
Newcastle disease virus lysate
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
Recombinant Fowlpox-B7.1 Vaccine
|
|
304
|
Cd86 |
Mus musculus |
|
12524
|
|
161484599
|
|
AC117662 |
NP_062261 |
|
|
transcript variant X2 |
Protective antigen |
Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
|
|
1304
|
CD86 |
Homo sapiens |
|
942
|
|
332634950
|
|
AC068630 |
NP_001193853 |
|
|
transcript variant 1 |
Other |
Autologous IL-2-expressing B-CLL Vaccine
Autologous Tumor Cell Vaccine
AUT-OV-ALVAC-hB7.1 Vaccine
|
|
4439
|
CD8A |
Homo sapiens |
|
925
|
|
225007536
|
|
AC064848 |
NP_001139345 |
|
|
transcript variant 4 |
Protective antigen |
Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
|
|
4591
|
CD90 |
Homo sapiens |
|
7070
|
|
902967471
|
|
AP003396 |
NP_001298089 |
|
|
transcript variant 5 |
Protective antigen |
Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
|
|
4759
|
CDH3 |
Homo sapiens |
|
1001
|
|
953953841
|
|
AC099314 |
NP_001304124 |
|
|
transcript variant X1 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4496
|
CDK1 |
Homo sapiens |
|
983
|
|
281427278
|
|
AC022390 |
NP_001163877 |
|
|
transcript variant 6 |
Protective antigen |
IMT-1012 Immunotherapeutic Vaccine
|
|
4471
|
cdsR |
Chlamydia trachomatis A/HAR-13 |
|
45091589
|
|
497557743
|
CTA_RS03050 |
CP000051 |
WP_009871927 |
|
|
SctR family type III secretion system export apparatus subunit CdsR |
Protective antigen |
Vaccinia Virus DD-CDSR Vaccine
|
|
4436
|
Cea-Mouse |
Mus musculus |
|
111518
|
|
|
|
|
|
|
|
carcinoembryonic antigen gene family |
Protective antigen |
Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
|
|
4535
|
CEACAM1 |
Homo sapiens |
|
634
|
|
68161541
|
|
A43165 |
NP_001020083 |
|
|
transcript variant 5 |
Protective antigen |
Mammaglobin-A DNA Vaccine
Fowlpox Virus Vaccine
|
|
316
|
CEACAM3 |
Homo sapiens |
|
1084
|
|
461496471
|
|
AC022516 |
NP_001264092 |
|
|
transcript variant 3 |
Protective antigen |
|
|
1351
|
CEACAM5 (CEA) |
Homo sapiens |
|
1048
|
|
612407802
|
|
AC008999 |
NP_001278413 |
|
|
transcript variant 1 |
Protective antigen |
Cancer Subunit DC (Tat-CEA) vaccine
Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
Adenoviral Vector Ad5-CEA(6D) Vaccine
Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
Inalimarev Vaccine
Fowlpox Virus Vaccine Vector
Falimarev Vaccine
Algenpantucel-L
Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
ALVAC-CEA Vaccine
ALVAC-CEA (VCP248)
ALVAC-B7-CEA
ALVAC-CEA (6D)-B7.1 Vaccine
Allogeneic Cellular Vaccine 1650-G
Carcinoembryonic Antigen Peptide 1-6D
Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
Carcinoembryonic Antigen Peptide-1 Vaccine
Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
Dendritic Cell-CEA Peptide Vaccine
Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
|
|
4568
|
CEACAM5 - obsolete |
Homo sapiens |
|
1048
|
|
612407802
|
|
AC008999 |
NP_001278413 |
|
|
transcript variant 1 |
Protective antigen |
EP-2101 Vaccine
Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
Recombinant Vaccinia-CEA Vaccine
|
|
4652
|
CHI3L1 |
Homo sapiens |
|
1116
|
|
144226251
|
|
AC105940 |
NP_001267 |
|
|
chitinase 3 like 1 |
Protective antigen |
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
4777
|
CLEC3B |
Homo sapiens |
|
7123
|
|
817473757
|
|
AC104165 |
NP_001295323 |
|
|
transcript variant X1 |
Protective antigen |
Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
|
|
4415
|
CLEC4C |
Homo sapiens |
|
170482
|
|
1701108502
|
|
AC006517 |
NP_001358319 |
|
|
transcript variant X3 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
4656
|
CRY2 |
Arabidopsis thaliana |
|
839529
|
|
15219720
|
AT1G04400 |
CP002684 |
NP_171935 |
|
|
|
Protective antigen |
|
|
4653
|
CSF1R |
Homo sapiens |
|
1436
|
|
569026720
|
|
AC011382 |
NP_001275634 |
|
|
transcript variant 3 |
Protective antigen |
|
|
4686
|
Csf2-Mouse |
Mus musculus |
|
12981
|
|
110625658
|
|
AL596103 |
NP_034099 |
|
|
transcript variant X1 |
Protective antigen |
Vaccinia-GM-CSF Vaccine
|
|
4783
|
CSH1 |
Homo sapiens |
|
1442
|
|
4503083
|
|
AC040958 |
NP_001308 |
|
|
chorionic somatomammotropin hormone 1 |
Protective antigen |
hTERT/Survivin/CMV Multipeptide Vaccine
|
|
4563
|
CTAG1B |
Homo sapiens |
|
1485
|
|
4503119
|
|
AC244107 |
NP_001318 |
|
|
cancer/testis antigen 1B |
Protective antigen |
Cancer Subunit NY-ESO-1 Protein Vaccine
Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
ALVAC(2) Melanoma Multi-antigen Vaccine
NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
NY-ESO-1 Peptide Vaccine
NY-ESO-1 Plasmid DNA Cancer Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
NY-ESO-1/GLA-SE Vaccine ID-G305AmN
NY-ESO-1/LAGE-1 Peptide Vaccine
NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
NY-ESO-1b Peptide Vaccine
NY-ESO-B Vaccine
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
Recombinant NY-ESO-1 ISCOMATRIX Vaccine
Recombinant Vaccinia-NY-ESO-1 Vaccine
short overlapping peptides and full-length recombinant protein
12 Melanoma Peptide Vaccine
MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
|
|
4567
|
CTAG2 |
Homo sapiens |
|
30848
|
|
543583752
|
|
AC244107 |
NP_066274 |
|
|
transcript variant 1 |
Protective antigen |
NY-ESO-1/LAGE-1 Peptide Vaccine
Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
|
|
710
|
CTLA4 |
Homo sapiens |
|
1493
|
|
83700231
|
|
AC010138 |
NP_001032720 |
1AH1
|
|
transcript variant 1 |
Protective antigen |
Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
ALVAC-hB7.1
GVAX Pancreatic Cancer Vaccine
GVAX Cancer Vaccine
|
|
4432
|
cupB5 |
Pseudomonas aeruginosa PAO1 |
|
878708
|
|
15599277
|
PA4082 |
AE004091 |
NP_252771 |
|
|
adhesive protein CupB5 |
Protective antigen |
|
|
1353
|
CYP1B1 |
Homo sapiens |
|
1545
|
|
189491763
|
|
ABBA01074989 |
NP_000095 |
|
|
cytochrome P450, family 1, subfamily B, polypeptide 1 |
Other |
|
|
1355
|
DCT |
Homo sapiens |
|
1638
|
|
193788640
|
|
AL139318 |
NP_001123361 |
|
|
transcript variant 1 |
Protective antigen |
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
Murine TYRP2 Plasmid DNA Vaccine
|
|
4685
|
DCT |
Homo sapiens |
|
1638
|
|
193788640
|
|
AL139318 |
NP_001123361 |
|
|
transcript variant X2 |
Protective antigen |
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
|
|
4462
|
DDR1 |
Homo sapiens |
|
780
|
|
321400059
|
|
AB088102 |
NP_001189450 |
|
|
transcript variant X8 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
|
|
4557
|
DEPDC1 |
Homo sapiens |
|
55635
|
|
166295188
|
|
AL138789 |
NP_001107592 |
|
|
transcript variant 2 |
Protective antigen |
Multipeptide Vaccine S-588210
DEPDC1/MPHOSH1 Peptide Vaccine
|
|
4644
|
DItox |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4659
|
E1B |
Human mastadenovirus C |
|
2652981
|
|
9626162
|
HAdVC_gp02 |
JX173077 |
NP_040510 |
|
|
control protein E1B 19K |
Protective antigen |
|
|
1684
|
E2A |
Mus musculus |
|
21423
|
|
255918153
|
|
AB095606 |
NP_001157619 |
|
|
transcript variant 8 |
Protective antigen |
Carcinoma DNA vaccine pVAX/E2A
|
|
4489
|
E6 |
Human papillomavirus type 16 |
|
1489078
|
|
9627104
|
HpV16gp1 |
AB663688 |
NP_041325 |
|
|
transforming protein E6 |
Protective antigen |
Amolimogene Bepiplasmid
Human Papillomavirus Tumor Antigen Vaccine
HPV DNA Plasmids Therapeutic Vaccine VGX-3100
Recombinant Vaccinia Viral Vector RO5217790 Vaccine
rMVTT- HPV16-E6/E7
Synthetic Long E6/E7 Peptides Vaccine HPV-01
DNA Vaccine VB10.16
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
HPV 16 E6 (18-26) Peptide Vaccine
Host Dendritic Cell Vaccine-001 MSSM/BIIR
|
|
4490
|
E7 |
Human papillomavirus type 16 |
|
1489079
|
|
9627105
|
HpV16gp2 |
AB663783 |
NP_041326 |
|
|
transforming protein E7 |
Protective antigen |
Amolimogene Bepiplasmid
Human Papillomavirus Tumor Antigen Vaccine
HPV DNA Plasmids Therapeutic Vaccine VGX-3100
HPV 16 E7:86-93 Peptide Vaccine
HPV 16 E7:12-20 Peptide Vaccine
Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
pNGVL4a-CRT/E7(detox) DNA Vaccine
pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
Recombinant Vaccinia Viral Vector RO5217790 Vaccine
rMVTT- HPV16-E6/E7
Synthetic Long E6/E7 Peptides Vaccine HPV-01
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
attenuated Listeria expressing cancer antigen vaccine
DNA Vaccine VB10.16
Human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
Verpasep Caltespen Vaccine
|
|
4561
|
EBNA-1 |
Human gammaherpesvirus 4 |
|
3783709
|
|
82503233
|
HHV4_EBNA-1.1 |
AB850647 |
YP_401677 |
|
|
mRNA |
Protective antigen |
MVA-EBNA1/LMP2 Vaccine
|
|
4413
|
EGFR |
Homo sapiens |
|
1956
|
|
1100818972
|
|
AB221348 |
NP_001333826 |
|
|
transcript variant 1 |
Protective antigen |
PF-04948568 Vaccine
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
PEP-3-KLH Conjugate Vaccine
Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
EGFRvIII Peptide Vaccine
|
|
4791
|
Emb |
Mus musculus |
|
13723
|
|
226437629
|
|
AC123935 |
NP_034460 |
|
|
embigin |
Protective antigen |
|
|
721
|
Eng |
Mus musculus |
|
13805
|
|
226437649
|
RP23-17P12.4 |
AL772271 |
NP_001139820 |
|
|
transcript variant 2 |
Protective antigen |
Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
|
|
4756
|
ENG |
Homo sapiens |
|
2022
|
|
4557555
|
|
AF035753 |
NP_000109 |
|
|
transcript variant 2 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4709
|
env |
Human immunodeficiency virus 1 |
|
155971
|
|
9629363
|
HIV1gp8 |
AF033819 |
NP_057856 |
|
|
Envelope surface glycoprotein gp160, precursor |
Protective antigen |
HIVgP160 Vaccine
AUT-OV-ALVAC-hB7.1 Vaccine
|
|
317
|
EPCAM |
Homo sapiens |
|
4072
|
|
218505670
|
|
AC079775 |
NP_002345 |
|
|
epithelial cell adhesion molecule |
Protective antigen |
Cancer EPCAM protein vaccine
KSA-KLH Conjugate Vaccine
Recombinant Colorectal cancer antigen GA733 Vaccine
|
|
4525
|
EPHA2 |
Homo sapiens |
|
1969
|
|
1041818018
|
|
AL451042 |
NP_001316019 |
|
|
transcript variant 2 |
Protective antigen |
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
296
|
ERBB2 |
Homo sapiens |
|
2064
|
|
54792098
|
RP23-355L10.8 |
AB025285 |
NP_001005862 |
|
|
transcript variant 3 |
Protective antigen |
Cancer Her-2/neu Protein Subunit Vaccine
Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
AE37 Peptide/GM-CSF Vaccine
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
Nelipepimut-S Plus GM-CSF Vaccine
EP-2101 Vaccine
pNGVL3-hICD Vaccine
Poly Microsphere Encapsulated HER2/neu Oral Vaccine
Recombinant dHER2 Vaccine
Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
Autologous GM-CSF-Secreting Breast Cancer Vaccine
Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
Lapuleucel-T Vaccine
CD80 Breast Cancer Vaccine
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
Mammaglobin-A DNA Vaccine
|
|
4731
|
Erbb2 |
Rattus norvegicus |
|
24337
|
|
77020289
|
|
AABR07030444 |
NP_058699 |
|
|
erb-b2 receptor tyrosine kinase 2 |
Protective antigen |
Adenovirus Encoding Rat HER-2/neu
|
|
4774
|
EWSR1 |
Homo sapiens |
|
2130
|
|
253970502
|
|
AB005538 |
NP_001156757 |
|
|
transcript variant X34 |
Protective antigen |
EF-1 Peptide Vaccine
|
|
302
|
Fasl |
Mus musculus |
|
14103
|
|
327478405
|
|
AC164414 |
NP_001192172 |
|
|
transcript variant 2 |
Protective antigen |
|
|
301
|
FASLG |
Homo sapiens |
|
356
|
|
4557329
|
|
AB013303 |
NP_000630 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4625
|
FCY1 |
Saccharomyces cerevisiae S288C |
|
856175
|
|
6325319
|
YPR062W |
BK006949 |
NP_015387 |
|
|
|
Protective antigen |
rMeV- SCD
|
|
4447
|
FGF2 |
Homo sapiens |
|
2247
|
|
1371565425
|
|
AC021205 |
NP_001348594 |
|
|
transcript variant 1 |
Protective antigen |
Adenovirus 5-Fibroblast Growth Factor 2
|
|
4430
|
FGF5 |
Homo sapiens |
|
2250
|
|
620597367
|
|
AC021127 |
NP_001278741 |
|
|
transcript variant 1 |
Protective antigen |
117-126:FGF-5 Peptide
HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine
|
|
4654
|
FIM3 |
Homo sapiens |
|
2279
|
|
|
|
|
|
|
|
Friend-murine leukemia virus integration site 3 homolog |
Protective antigen |
|
|
4775
|
FL1 |
Homo sapiens |
|
100306940
|
|
|
|
|
|
|
|
Follicular lymphoma, susceptibility to, 1 |
Protective antigen |
EF-1 Peptide Vaccine
|
|
4477
|
FLT1 |
Homo sapiens |
|
2321
|
|
229892220
|
|
AL138712 |
NP_001153392 |
|
|
transcript variant X1 |
Protective antigen |
VEGFR1-1084 Peptide Vaccine
|
|
298
|
Flt3 |
Mus musculus |
|
14255
|
|
122937353
|
|
AC127549 |
NP_034359 |
|
|
transcript variant X2 |
Protective antigen |
|
|
4507
|
FLT3LG |
Homo sapiens |
|
2323
|
|
325197197
|
|
AC010619 |
NP_001191431 |
|
|
transcript variant X16 |
Protective antigen |
HPV E6/E7 DNA Vaccine GX-188E
|
|
4622
|
FOLH1 |
Homo sapiens |
|
2346
|
|
62548858
|
|
AC110742 |
NP_001014986 |
|
|
transcript variant X5 |
Protective antigen |
PSA/PSMA DNA Plasmid INO-5150 Vaccine
|
|
4452
|
FOLR1 |
Homo sapiens |
|
2348
|
|
4758400
|
|
AP000812 |
NP_000793 |
|
|
transcript variant 7 |
Protective antigen |
Multi-epitope Folate Receptor Alpha Peptide Vaccine
Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
Folate-FITC Vaccine
Retroviral Vector MFGS-MOv18-gamma Vaccine
|
|
1388
|
Fosl1 |
Mus musculus |
|
14283
|
|
6753896
|
|
AC122861 |
NP_034365 |
|
|
fos-like antigen 1 |
Protective antigen |
|
|
4572
|
FOXO1 |
Homo sapiens |
|
2308
|
|
9257222
|
|
AL133318 |
NP_002006 |
|
|
transcript variant X1 |
Protective antigen |
PAX3/FKHR Peptide Vaccine
|
|
1332
|
Fragment C from tetanus toxin |
Clostridium tetani |
|
|
|
8132375
|
|
|
|
|
CDD:285228
CDD:285226 |
tetanus toxin |
Protective antigen |
Cancer DNA vaccine p.DOM-AH1 encoding fragment C
Lymphoma DNA vaccine VαVβVβ-FrC
|
|
4668
|
FUS |
Homo sapiens |
|
2521
|
|
283135201
|
|
AC009088 |
NP_001164105 |
|
|
transcript variant 2 |
Protective antigen |
Canarypox-hIL-12 Melanoma Vaccine
|
|
4584
|
GAA |
Homo sapiens |
|
2548
|
|
119393891
|
|
AC087741 |
NP_000143 |
|
|
transcript variant 4 |
Protective antigen |
Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
|
|
4798
|
GALC |
Homo sapiens |
|
2581
|
|
83281450
|
|
AH003226 |
NP_000144 |
|
|
transcript variant 4 |
Protective antigen |
Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells
|
|
4713
|
Gla |
Mus musculus |
|
11605
|
|
133778924
|
|
BX004852 |
NP_038491 |
|
|
transcript variant X1 |
Protective antigen |
Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine
|
|
4705
|
GLIPR1 |
Homo sapiens |
|
11010
|
|
110825980
|
|
AC022507 |
NP_006842 |
|
|
transcript variant X1 |
Protective antigen |
AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
|
|
4473
|
GM-CSF |
Papio anubis |
|
100137216
|
|
281182592
|
|
DP000485 |
NP_001162225 |
|
|
granulocyte-macrophage colony-stimulating factor |
Protective antigen |
Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine
|
|
4449
|
GM-CSF (human) |
Homo sapiens |
|
1437
|
|
27437030
|
|
AC004511 |
NP_000749 |
|
|
colony stimulating factor 2 |
Protective antigen |
Pexastimogene-devacirepvec Vaccine
Oncolytic Adenovirus Encoding GM-CSF Vaccine
AE37 Peptide/GM-CSF Vaccine
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
GVAX Lung Cancer Vaccine
PSA/IL-2/GM-CSF Vaccine
Recombinant Fowlpox GM-CSF Vaccine Adjuvant
Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
|
|
1338
|
GM-CSF (Mus musculus) |
Mus musculus |
|
12981
|
|
110625658
|
RP23-309E16.1 |
AL596103 |
NP_034099 |
|
|
transcript variant X1 |
Protective antigen |
Melanoma DNA vaccine pNL3-MAGE-1-GM
Melanoma DNA vaccine pN4a-MAGE-1-GM
|
|
4586
|
GM2A |
Homo sapiens |
|
2760
|
|
39995109
|
|
AC008385 |
NP_000396 |
|
|
transcript variant 1 |
Protective antigen |
GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
|
|
4721
|
GNRH1 |
Homo sapiens |
|
2796
|
|
395394022
|
|
AC091185 |
NP_000816 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4741
|
Gnrh1 |
Mus musculus |
|
14714
|
|
51093849
|
|
AC093020 |
NP_032171 |
|
|
transcript variant 2 |
Protective antigen |
Anti-GnRH Vaccine PEP223
|
|
1341
|
gp100 (PMEL) |
Homo sapiens |
|
6490
|
|
318037593
|
|
AC025162 |
NP_001186982 |
|
|
transcript variant 3 |
Protective antigen |
Melanoma DNA vaccine hugp100 encoding gp100
ALVAC(2) Melanoma Multi-antigen Vaccine
HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
MART-1:26-35(27L) Peptide Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
gp100:209-217 Peptide Vaccine
gp100:154-162 Peptide Vaccine
gp100: ES209-217(210M) Peptide Vaccine
gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
gp100-Pulsed Peripheral Blood Mononuclear Cell Vaccine
gp100-Fowlpox Vaccine
gp100 Vaccinia Vaccine
gp100 Protein (184V) Vaccine
gp100 and GM-CSF DNA/Gold Vaccine
gp100 Adenovirus Vaccine
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
Dendritic Cell-gp100-MART-1 Antigen Vaccine
Autologous TriMix-DC Melanoma Vaccine
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
Alpha-type-1 Polarized Dendritic Cells
Antigen-targeted Personalized Breast Cancer Vaccine
Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
27-35(27L):MART-1 peptide vaccine
Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine
MELITAC 12.1 Peptide Vaccine
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
Multivalent immunotherapeutic vaccine
NA17.A2 Peptide Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
gp100:280-288 Peptide Vaccine
Recombinant Fowlpox-gp100p209 Vaccine
Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
Recombinant Vaccinia-gp100:209-217 Vaccine
Recombinant Vaccinia-Mgp100 Vaccine
ALVAC gp100 Vaccine
|
|
4788
|
gp160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4493
|
gp72 |
Human herpesvirus 4 type 2 |
|
5176180
|
|
139424541
|
HHV4tp2_gp72 |
|
YP_001129507 |
|
|
BALF5 |
Protective antigen |
Interleukin-2 Anti-Idiotype Vaccine
|
|
1357
|
GPC3 |
Homo sapiens |
|
2719
|
|
257471006
|
AC002420.1 |
AC002420 |
NP_001158089 |
|
|
transcript variant 4 |
Protective antigen |
|
|
4689
|
GPR183 |
Homo sapiens |
|
1880
|
|
4826706
|
|
AL160155 |
NP_004942 |
|
|
transcript variant X1 |
Protective antigen |
Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
|
|
4434
|
GPT |
Homo sapiens |
|
2875
|
|
1843419814
|
|
AC084125 |
NP_001369593 |
|
|
transcript variant 4 |
Protective antigen |
Ad CMV I kappaB alpha
|
|
4587
|
GRDX |
Homo sapiens |
|
117189
|
|
|
|
|
|
|
|
Graves disease, susceptibility to, X-linked |
Protective antigen |
GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
|
|
4649
|
GRIN1 |
Homo sapiens |
|
2902
|
|
11496971
|
|
AL929554 |
NP_000823 |
|
|
transcript variant X1 |
Protective antigen |
DNA Plasmid Encoding Interleukin-12 INO-9012
|
|
1686
|
GRP |
Homo sapiens |
|
2922
|
|
60498997
|
|
AC067859 |
NP_001012530 |
|
|
transcript variant X3 |
Protective antigen |
Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP
|
|
4730
|
GUCY2C |
Homo sapiens |
|
2984
|
|
222080083
|
|
AC007545 |
NP_004954 |
|
|
transcript variant X1 |
Protective antigen |
Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine
|
|
292
|
H2-K1 |
Mus musculus |
|
14972
|
|
133922588
|
|
AB114280 |
NP_001001892 |
|
|
transcript variant X11 |
Protective antigen |
Cancer recombinant vector vaccine encoding H-2Kb
Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
|
|
4438
|
HA |
Influenza A virus (A/California/07/2009(H1N1)) |
|
23308115
|
|
758899356
|
UJ99_s4gp1 |
FJ969540 |
YP_009118626 |
|
|
hemagglutinin |
Protective antigen |
|
|
4802
|
HBB |
Homo sapiens |
|
3043
|
|
4504349
|
|
A01592 |
NP_000509 |
|
|
hemoglobin subunit beta |
Protective antigen |
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
4578
|
HBsAg |
Hepatitis B virus |
|
944569
|
|
941241316
|
HBVgp2 |
AF372622 |
YP_009173869 |
|
|
large envelope protein |
Protective antigen |
|
|
4448
|
HER2-Dupli |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4947
|
HLA-A |
Homo sapiens |
|
3105
|
|
337752170
|
|
AB005048 |
NP_001229687 |
|
|
transcript variant 1 (A*03:01:01:01) |
Protective antigen |
Renal Cell Carcinoma Peptides Vaccine IMA901
|
|
4683
|
HLA-B |
Homo sapiens |
|
3106
|
|
17986001
|
|
AB030573 |
NP_005505 |
|
|
major histocompatibility complex, class I, B |
Protective antigen |
Renal Cell Carcinoma Peptides Vaccine IMA901
|
|
4682
|
HLA-DRB1 |
Homo sapiens |
|
3123
|
|
345461076
|
|
AB007634 |
NP_001230894 |
|
|
transcript variant 1 |
Protective antigen |
Autologous Melanoma Lysate/KLH-Pulsed Autologous Dendritic Cell Vaccine
Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine
|
|
4505
|
HPV6 E6 |
Human papillomavirus type 6 |
|
2829163
|
|
|
|
|
|
|
|
Record to support submission of GeneRIFs for a gene not in Gene (human papillomavirus type 6 HPV-6). |
Protective antigen |
HPV-6-targeting Immunotherapeutic Vaccine INO-3106
|
|
4506
|
HPV6 E6 |
Human papillomavirus type 6 |
|
2829163
|
|
|
|
|
|
|
|
Record to support submission of GeneRIFs for a gene not in Gene (human papillomavirus type 6 HPV-6). |
Protective antigen |
Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
|
|
4944
|
HRAS |
Homo sapiens |
|
3265
|
|
194363762
|
|
AC137894 |
NP_001123914 |
|
|
transcript variant 1 |
Protective antigen |
Racotumomab Vaccine
|
|
1350
|
HSP47 |
Mus musculus |
|
|
|
51450
|
|
|
|
|
CDD:239001
GOA:P19324
InterPro: IPR000215
UniProtKB/UniProt: P19324 |
heat shock protein |
Protective antigen |
Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
|
|
4581
|
HSP90B1 |
Homo sapiens |
|
7184
|
|
4507677
|
|
AC078819 |
NP_003290 |
|
|
heat shock protein 90 beta family member 1 |
Protective antigen |
Viagenpumatucel-L Vaccine
gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410
|
|
4687
|
HSPA4 |
Homo sapiens |
|
3308
|
|
38327039
|
|
AC113410 |
NP_002145 |
|
|
heat shock protein family A (Hsp70) member 4 |
Protective antigen |
Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
|
|
4481
|
HSPD1 |
Homo sapiens |
|
3329
|
|
31542947
|
|
AC010746 |
NP_002147 |
|
|
transcript variant 2 |
Protective antigen |
Verpasep Caltespen Vaccine
|
|
1343
|
HuD |
Homo sapiens |
|
1996
|
|
221316767
|
|
AL583843 |
NP_001138246 |
|
|
transcript variant 7 |
Protective antigen |
Neuroblastoma DNA vaccine HuDsec
|
|
4669
|
human TP53 (P53) |
Homo sapiens |
|
7157
|
|
120407068
|
|
AB118156 |
NP_000537 |
|
|
transcript variant 2 |
Protective antigen |
ALVAC-P53 Vaccine
Modified Vaccinia Virus Ankara Vaccine Expressing p53
EP-2101 Vaccine
p53 Peptide Vaccine
Autologous Dendritic Cell-Adenovirus P53 Vaccine
Contusugene ladenovec
Adenovirus-p53 Transduced Dendritic Cell Vaccine
Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes Vaccine
Berzofsky Ras/P53 Peptide Vaccine
Long Peptide Vaccine 7
ONYX-015 Vaccine
Recombinant Adenovirus-p53 SCH-58500 Vaccine
|
|
1685
|
HUMGP 75 |
Homo sapiens |
|
|
|
1067130
|
|
|
|
|
CDD:278682
GDB:126337
GOA:P17643
HGNC:HGNC:12450
InterPro: IPR002227
InterPro: IPR008922
InterPro: IPR015559
UniProtKB/UniProt: P17643 |
melanoma antigen gp 75 |
Protective antigen |
Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
|
|
4612
|
ICAM1 |
Homo sapiens |
|
3383
|
|
167466198
|
|
AC011511 |
NP_000192 |
|
|
intercellular adhesion molecule 1 |
Protective antigen |
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Fowlpox-TRICOM Vaccine
Rilimogene-galvacirepvec Vaccine
Autologous IL-2-expressing B-CLL Vaccine
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
Brain Tumor Initiating Cell Vaccine
|
|
4666
|
ID1 |
Homo sapiens |
|
3397
|
|
31317299
|
|
AL110115 |
NP_002156 |
|
|
transcript variant 2 |
Protective antigen |
Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine
|
|
4498
|
IDH1 |
Homo sapiens |
|
3417
|
|
538917488
|
|
AC016697 |
NP_001269315 |
|
|
transcript variant 2 |
Protective antigen |
IDH1R132H-Specific Peptide Vaccine PEPIDH1M
IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
|
|
4804
|
IDO1 |
Homo sapiens |
|
3620
|
|
4504577
|
|
AC007991 |
NP_002155 |
|
|
indoleamine 2,3-dioxygenase 1 |
Protective antigen |
Indoleamine 2,3-dioxygenase Peptide Vaccine
|
|
4603
|
IFNA2 |
Homo sapiens |
|
3440
|
|
11067751
|
|
AL353732 |
NP_000596 |
|
|
interferon alpha 2 |
Protective antigen |
Recombinant Adenovirus-Interferon/Syn3 Vaccine
|
|
4604
|
IFNB1 |
Homo sapiens |
|
3456
|
|
4504603
|
|
AL390882 |
NP_002167 |
|
|
interferon beta 1 |
Protective antigen |
Recombinant Adenovirus-hIFN-beta Vaccine
|
|
4703
|
IFNG |
Homo sapiens |
|
3458
|
|
56786138
|
|
AC007458 |
NP_000610 |
|
|
interferon gamma |
Protective antigen |
Allogeneic Dendritic Cell Vaccine COMBIG-DC
ALVAC Vaccine
|
|
4716
|
IFNG- Obsolete |
Homo sapiens |
|
3458
|
|
56786138
|
|
AC007458 |
NP_000610 |
|
|
interferon gamma |
Protective antigen |
|
|
4538
|
IFNL3 |
Homo sapiens |
|
282617
|
|
1100961536
|
|
AC011445 |
NP_001333866 |
|
|
transcript variant 2 |
Protective antigen |
Melanoma Theraccine
|
|
4469
|
IGF2BP3 |
Homo sapiens |
|
10643
|
|
30795212
|
|
AC005082 |
NP_006538 |
|
|
transcript variant X1 |
Protective antigen |
URLC10-CDCA1-KOC1 Multipeptide Vaccine
URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
Multipeptide Vaccine S-588210
Recombinant Adenovirus-L523S Vaccine
Recombinant DNA-L523S Vaccine
|
|
4598
|
IGFBP1 |
Homo sapiens |
|
3484
|
|
4504615
|
|
AC091524 |
NP_000587 |
|
|
insulin like growth factor binding protein 1 |
Protective antigen |
pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine
|
|
1688
|
IgG Fc |
Homo sapiens |
|
8857
|
|
154146262
|
|
AC006950 |
NP_003881 |
|
|
Fc fragment of IgG binding protein |
Protective antigen |
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
|
|
4696
|
IGHG1 |
Homo sapiens |
|
3500
|
|
|
|
AL122127 |
|
|
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
Protective antigen |
|
|
4564
|
IL12 |
Sus scrofa |
|
107653060
|
|
|
|
|
|
|
|
Interleukin 12 level |
Protective antigen |
Natural Killer Cells ZRx101 Vaccine
Oncovax-ID/IL-2 Vaccine
PSA/IL-2/GM-CSF Vaccine
SRL172
|
|
4744
|
IL12A |
Homo sapiens |
|
3592
|
|
24430219
|
|
AC010370 |
NP_000873 |
|
|
transcript variant 1 |
Protective antigen |
Ad5-yCD/mutTKSR39rep-hIL12
|
|
4699
|
IL12B |
Homo sapiens |
|
3593
|
|
24497438
|
|
AC011418 |
NP_002178 |
|
|
interleukin 12B |
Protective antigen |
Ad5-yCD/mutTKSR39rep-hIL12
Adenovirus-mediated Human Interleukin-12
|
|
4553
|
IL13RA2 |
Homo sapiens |
|
3598
|
|
10834992
|
|
AH012718 |
NP_000631 |
|
|
interleukin 13 receptor subunit alpha 2 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
1389
|
Il18 |
Mus musculus |
|
16173
|
|
1269208322
|
|
AC025500 |
NP_001344150 |
|
|
transcript variant X2 |
Protective antigen |
|
|
4674
|
IL2 |
Homo sapiens |
|
3558
|
|
28178861
|
|
AC022489 |
NP_000577 |
|
|
interleukin 2 |
Protective antigen |
Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine
Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
|
|
4745
|
IL2-Duplicate |
Homo sapiens |
|
3558
|
|
28178861
|
|
AC022489 |
NP_000577 |
|
|
interleukin 2 |
Protective antigen |
|
|
4445
|
IL24 |
Homo sapiens |
|
11009
|
|
297632401
|
|
AC098935 |
NP_001172085 |
|
|
transcript variant X2 |
Protective antigen |
Adenovector Encoding MDA7
|
|
4414
|
IL3RA |
Homo sapiens |
|
3563
|
|
391224440
|
|
AL683870 |
NP_001254642 |
|
|
transcript variant X3 |
Protective antigen |
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
1683
|
Immunoglobulin |
Homo sapiens |
|
|
|
1945467
|
|
|
|
|
CDD:299845
CDD:214653 |
immunoglobulin heavy chain |
Protective antigen |
B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions
|
|
4463
|
ITGB8 |
Homo sapiens |
|
3696
|
|
4504779
|
|
AC004130 |
NP_002205 |
|
|
transcript variant X3 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
|
|
4710
|
ITIH4 |
Homo sapiens |
|
3700
|
|
262050538
|
|
AC006254 |
NP_001159921 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4461
|
JUP |
Homo sapiens |
|
3728
|
|
1209185293
|
|
AC109319 |
NP_001339702 |
|
|
transcript variant 4 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
|
|
720
|
KDR |
Homo sapiens |
|
3791
|
|
11321597
|
|
AC021220 |
NP_002244 |
|
|
kinase insert domain receptor |
Protective antigen |
HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
HLA-A*2402-Restricted VEGFR1/2 Multipeptide Vaccine
HLA-A*2402-Restricted VEGFR1 Peptide Vaccine
HLA-A*0201-Restricted VEGFR1 Peptide Vaccine
HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
VEGFR-2 DNA Vaccine VXM01
|
|
4794
|
Kdr |
Mus musculus |
|
16542
|
|
1388591307
|
|
AC124615 |
NP_001350145 |
|
|
transcript variant 1 |
Protective antigen |
VEGFR2-169 Peptide Vaccine
|
|
4558
|
KIF20B |
Homo sapiens |
|
9585
|
|
546231677
|
|
AL157389 |
NP_001271188 |
|
|
transcript variant 4 |
Protective antigen |
Multipeptide Vaccine S-588210
DEPDC1/MPHOSH1 Peptide Vaccine
|
|
717
|
KLK3 |
Homo sapiens |
|
354
|
|
71834853
|
|
AC011523 |
NP_001025218 |
|
|
transcript variant 3 |
Protective antigen |
MVA-PSA/PAP Prostate Cancer Vaccine
Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine
PROSTVAC-Contaminated W/ BVDV
PSA Prostate Cancer Vaccine
PSA-OP Peptide Vaccine
PSA:154-163(155L) Peptide Vaccine
PSMA/TARP Peptide Vaccine
pVAXrcPSAv53l DNA Vaccine
Recombinant Fowlpox-Prostate Specific Antigen Vaccine
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Vaccinia DF3/MUC1 Vaccine
Recombinant Vaccinia-Prostate Specific Antigen Vaccine
Recombinant Vaccinia-PSA/PSMA Vaccine
rF-PSA/PSMA/TRICOM Vaccine
Rilimogene-galvacirepvec Vaccine
Fowlpox-PSA-TRICOM Vaccine
GVAX Cancer Vaccine
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
Prostate cancer DNA vaccine pVAX/PSA encoding PSA
APC8015F
Fowlpox Virus Vaccine
PSA RNA-Pulsed Dendritic Cell Vaccine
Recombinant Vaccinia PSA Vaccine
|
|
1334
|
KLK3-Dupli |
Homo sapiens |
|
|
|
20520643
|
|
|
|
|
CDD:238113
GOA:Q546G3
HGNC:HGNC:6364
InterPro: IPR001254
InterPro: IPR001314
InterPro: IPR009003
InterPro: IPR018114
UniProtKB/TrEMBL: Q546G3 |
prostate specific antigen |
Protective antigen |
|
|
4444
|
KRAS |
Homo sapiens |
|
3845
|
|
1621312269
|
|
AC087239 |
NP_001356715 |
|
|
transcript variant d |
Protective antigen |
HCV DNA Vaccine INO-8000
RAS Peptide Cancer Vaccine
RASVAC-C Vaccine
RASVAC-V Vaccine
RCAS-Ras Vaccine
Long Peptide Vaccine 7
Racotumomab Vaccine
|
|
4942
|
KRAS |
Homo sapiens |
|
3845
|
|
1621312269
|
|
AC087239 |
NP_001356715 |
|
|
transcript variant d |
Protective antigen |
|
|
4441
|
L1 |
Human papillomavirus |
|
25479185
|
|
922073271
|
AMQ97_gp6 |
KP692117 |
YP_009163896 |
|
|
L1 |
Protective antigen |
HPV 16 L1-VLP Vaccine
Recombinant Human Papillomavirus Nonavalent Vaccine
Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
|
|
4946
|
lacZ |
Escherichia coli str. K-12 substr. MG1655 |
|
945006
|
|
16128329
|
b0344 |
CP009685 |
NP_414878 |
|
|
beta-galactosidase |
Protective antigen |
Recombinant Adenovirus-LacZ Vaccine
|
|
4531
|
LADD-Ag |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809
|
|
4631
|
LILRA2 |
Homo sapiens |
|
11027
|
|
590122028
|
|
AC009892 |
NP_001124389 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4728
|
LMP-1 |
Human gammaherpesvirus 4 |
|
3783750
|
|
82503278
|
HHV4_LMP-1 |
AB850647 |
YP_401722 |
|
|
mRNA |
Protective antigen |
Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
|
|
4729
|
LMP-2A |
Human gammaherpesvirus 4 |
|
3783751
|
|
82503189
|
HHV4_LMP-2A |
AJ507799 |
YP_401631 |
|
|
mRNA |
Protective antigen |
Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
|
|
4615
|
LV28_RS26095 transcriptional regulator RegF |
Pandoraea pnomenusa |
|
25003478
|
|
560176903
|
LV28_RS26095 |
CABPSO010000005 |
WP_023593906 |
|
|
glutathione S-transferase N-terminal domain-containing protein |
Protective antigen |
Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
|
|
4467
|
LY6K |
Homo sapiens |
|
54742
|
|
237858795
|
|
AC108002 |
NP_001153826 |
|
|
transcript variant X2 |
Protective antigen |
URLC10 Peptide Vaccine
URLC10-CDCA1-KOC1 Multipeptide Vaccine
URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
Multipeptide Vaccine S-588210
HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
|
|
1600
|
MAGE-1 |
Homo sapiens |
|
|
|
416115
|
|
|
|
|
CDD:289225
CDD:279759 |
MAGE-1 |
Protective antigen |
MG1-hDCT Vaccine
Tetravalent RNA-lipoplex Cancer Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
|
|
4786
|
MAGEA1 (MAGE1) |
Homo sapiens |
|
4100
|
|
148276977
|
|
AC152005 |
NP_004979 |
|
|
MAGE family member A1 |
Protective antigen |
HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
MAGE-1 Vaccinia Contaminated with BVDV
MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
Melanoma DNA vaccine pN4a-MAGE-1-GM
Melanoma DNA vaccine pNL3-MAGE-1-GM
MELITAC 12.1 Peptide Vaccine
|
|
4511
|
MAGEA1-Duplicate |
|
|
|
|
|
|
|
|
|
|
|
|
Multivalent immunotherapeutic vaccine
|
|
4818
|
MAGEA10 |
Homo sapiens |
|
4109
|
|
1890326744
|
|
AC116666 |
NP_001011543 |
|
|
transcript variant 2 |
Protective antigen |
MELITAC 12.1 Peptide Vaccine
|
|
4569
|
MAGEA2 |
Homo sapiens |
|
4101
|
|
542133120
|
|
AC244102 |
NP_001269430 |
|
|
transcript variant X1 |
Protective antigen |
EP-2101 Vaccine
Allogeneic Cellular Vaccine 1650-G
|
|
708
|
MAGEA3 |
Homo sapiens |
|
4102
|
|
4885467
|
|
AC244102 |
NP_005353 |
|
|
transcript variant X2 |
Protective antigen |
Melan-A/MAGE-3.DP4 Peptide Vaccine
Immunotherapeutic GSK1572932A
HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
MAGE-3.A1 Peptide Vaccine
MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
MAGE-A3 Peptide Vaccine
MAGE-A3-expressing Adenovirus Type 5 Vaccine
MAGE-A3/HPV 16 Peptide Vaccine
MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
NA17.A2 Peptide Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
EP-2101 Vaccine
Autologous TriMix-DC Melanoma Vaccine
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
Autologous-Cell Leukemia Vaccine
MELITAC 12.1 Peptide Vaccine
4-peptide melanoma vaccine
|
|
4732
|
MAGEA6 |
Homo sapiens |
|
4105
|
|
4885469
|
|
AC244102 |
NP_005354 |
|
|
transcript variant 1 |
Protective antigen |
Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
|
|
4637
|
MAGEA9 |
Homo sapiens |
|
4108
|
|
4885473
|
|
AC016939 |
NP_005356 |
|
|
transcript variant X1 |
Protective antigen |
G250 Peptide Vaccine
|
|
4740
|
MAGEC1 |
Homo sapiens |
|
9947
|
|
58530876
|
|
AF064589 |
NP_005453 |
|
|
transcript variant X1 |
Protective antigen |
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
|
|
4675
|
MAGEC2 |
Homo sapiens |
|
51438
|
|
7706605
|
|
AF116195 |
NP_057333 |
|
|
MAGE family member C2 |
Protective antigen |
Autologous TriMix-DC Melanoma Vaccine
|
|
4501
|
major capsid protein L1 |
|
|
|
|
|
|
|
|
|
|
|
|
Human Papillomavirus Vaccine V503
|
|
4636
|
MBL2 |
Homo sapiens |
|
4153
|
|
4557739
|
|
AB025350 |
NP_000233 |
|
|
transcript variant 2 |
Protective antigen |
TBC-CEA-Contaminated W/ BVDV Vaccine
|
|
1339
|
Mcam |
Mus musculus |
|
84004
|
|
1327848422
|
|
AC148328 |
NP_001346459 |
|
|
transcript variant X2 |
Protective antigen |
Melanoma DNA vaccine SINCp c-muMUC18 encoding MCAM/MUC18
|
|
4760
|
MDM2 |
Homo sapiens |
|
4193
|
|
223890201
|
|
AC025423 |
NP_001138809 |
|
|
transcript variant X3 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4543
|
MFGE8 |
Homo sapiens |
|
4240
|
|
167830477
|
|
AC067805 |
NP_001108086 |
|
|
transcript variant X2 |
Protective antigen |
Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
|
|
4551
|
MGMT |
Homo sapiens |
|
4255
|
|
1434110720
|
|
AH007347 |
NP_002403 |
|
|
transcript variant X1 |
Protective antigen |
MSCV-MGMT(P140K) Vaccine
|
|
4629
|
Mice Gene |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
|
|
706
|
MLANA |
Homo sapiens |
|
2315
|
|
5031913
|
RP11-546N22.1 |
AL365360 |
NP_005502 |
|
|
melan-A |
Protective antigen |
MART-1:26-35(27L) Peptide Vaccine
MART-1:27-35 Peptide Vaccine
Melan-A VLP Vaccine
Melan-A/MAGE-3.DP4 Peptide Vaccine
27-35(27L):MART-1 peptide vaccine
ALVAC-MART-1 Vaccine
HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
Multivalent immunotherapeutic vaccine
NA17.A2 Peptide Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
Dendritic Cell-MART-1 Peptide Vaccine
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
Alpha-type-1 Polarized Dendritic Cells
Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
Dendritic Cell-gp100-MART-1 Antigen Vaccine
Autologous-Cell Leukemia Vaccine
Gag:267-274 Peptide Vaccine
MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
|
|
4621
|
MLANA-Dupli |
Homo sapiens |
|
2315
|
|
5031913
|
|
AL365360 |
NP_005502 |
|
|
melan-A |
Protective antigen |
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
Synchrovax SEM Plasmid DNA Vaccine
Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
MART-1 Adenovirus Vaccine
MART-1 Fowlpox Vaccine
MART-1 Vaccinia Vaccine
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
|
|
313
|
mouse Trp53 |
Mus musculus |
|
22059
|
|
187960040
|
RP23-56I20.1 |
AF074575 |
NP_001120705 |
|
|
transcript variant 2 |
Protective antigen |
Mutant p53 Peptide Pulsed Dendritic Cell Vaccine
PR-151 Peptide Vaccine
Telomerase Peptide Vaccine GV1001
|
|
4548
|
MOV10 |
Homo sapiens |
|
4343
|
|
194272168
|
|
AL603832 |
NP_001123551 |
|
|
transcript variant X7 |
Protective antigen |
MOv-PBL Vaccine
|
|
4664
|
MS4A1 |
Homo sapiens |
|
931
|
|
23110987
|
|
AB520824 |
NP_068769 |
|
|
transcript variant 3 |
Protective antigen |
Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine
Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine
|
|
4712
|
MSLN |
Homo sapiens |
|
10232
|
|
293651530
|
|
AE006464 |
NP_001170826 |
|
|
transcript variant 1 |
Protective antigen |
Algenpantucel-L
Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine
Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine
|
|
703
|
MUC1 |
Homo sapiens |
|
4582
|
|
67189007
|
RP11-263K19.2 |
AC234582 |
NP_001018016 |
|
|
transcript variant 14 |
Protective antigen |
Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1
Synthetic MUC1 Peptide Vaccine
Anti-idiotype MUC-1 Monoclonal Antibody Vaccine
Inalimarev Vaccine
Liposomal MUC1/PET-lipid A Vaccine
Mammaglobin-A DNA Vaccine
MUC-1 Peptide Vaccine
MUC1 Antigen/SB AS-2 Vaccine
MUC1-KLH Conjugate Vaccine
MUC1-KLH Vaccine/QS21
MUC1-targeted Peptide GO-203-2C Vaccine
MVA-MUC1-IL2 Vaccine
Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
PSA:154-163 Peptide Vaccine
Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine
Recombinant Vaccinia DF3/MUC1 Vaccine
Recombinant Vaccinia-MUC-1 Vaccine
Recombinant Vaccinia-MUC1-B7 Vaccine
rF-MUC1(DF3)/TRICOM Vaccine
Fowlpox Virus Vaccine Vector
Falimarev Vaccine
Emepepimut-S Vaccine
Autologous Dendritic Cell-Tumor Fusion Vaccine
Ad-sig-hMUC-1/ecdCD40L Vaccine
|
|
1340
|
Muc1 |
Mus musculus |
|
17829
|
|
7305293
|
|
AC132327 |
NP_038633 |
|
|
mucin 1, transmembrane |
Protective antigen |
Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1
|
|
4811
|
MUC16 |
Homo sapiens |
|
94025
|
|
83367077
|
|
AC008734 |
NP_078966 |
|
|
transcript variant X12 |
Protective antigen |
Abagovomab
|
|
4552
|
MUC2 |
Homo sapiens |
|
4583
|
|
1083917512
|
|
AC139749 |
NP_002448 |
|
|
mucin 2, oligomeric mucus/gel-forming |
Protective antigen |
MUC-2-Globo H-KLH Conjugate Vaccine
MUC-2-KLH Vaccine
|
|
4537
|
MUC5B |
Homo sapiens |
|
727897
|
|
301172750
|
|
AC061979 |
NP_002449 |
|
|
mucin 5B, oligomeric mucus/gel-forming |
Protective antigen |
Maraba virus MG1 Vaccine
|
|
4605
|
NF2 |
Homo sapiens |
|
4771
|
|
4557795
|
|
AC004882 |
NP_000259 |
|
|
transcript variant 14 |
Protective antigen |
Recombinant Adenovirus-p53 SCH-58500 Vaccine
|
|
4943
|
NRAS |
Homo sapiens |
|
4893
|
|
4505451
|
|
AH001530 |
NP_002515 |
|
|
NRAS proto-oncogene, GTPase |
Protective antigen |
Racotumomab Vaccine
|
|
4575
|
NRP1 |
Homo sapiens |
|
8829
|
|
1844084060
|
|
AF482431 |
NP_001019799 |
|
|
transcript variant 6 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
4681
|
NSCLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4468
|
NUF2 |
Homo sapiens |
|
83540
|
|
117968353
|
|
AL592435 |
NP_113611 |
|
|
transcript variant X3 |
Protective antigen |
URLC10-CDCA1-KOC1 Multipeptide Vaccine
Multipeptide Vaccine S-588210
|
|
4589
|
NY-ESO-1 |
Homo sapiens |
|
1485
|
|
4503119
|
|
AC244107 |
NP_001318 |
|
|
cancer/testis antigen 1B |
Protective antigen |
Fowlpox-NY-ESO-1 Vaccine
ESO-1:157-165(165V) Peptide Vaccine
ESO-1 Reactive Autologous Peripheral Blood Lymphocyte Vaccine
ESO-1 (161-180) Peptide Vaccine
Dendritic Cell-targeting Lentiviral Vector ID-LV305
Autologous Melanoma Lysate/NY-ESO-1-pulsed Autologous Dendritic Cell Vaccine
Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
ALVAC-ESO-1 Vaccine
Ag NY-ESO-1
MELITAC 12.1 Peptide Vaccine
|
|
4817
|
ny-eso-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4528
|
ORF68 |
Human alphaherpesvirus 3 |
|
1487709
|
|
9625942
|
HHV3_gp69 |
AH010255 |
NP_040190 |
|
|
envelope glycoprotein E |
Protective antigen |
|
|
4435
|
P10 |
|
|
|
|
|
|
|
|
|
|
|
|
Mimotope-P10s-PADRE Peptide Vaccine
|
|
4509
|
PAEP |
Homo sapiens |
|
5047
|
|
937226996
|
|
AL354761 |
NP_001018058 |
|
|
transcript variant X8 |
Protective antigen |
HLA-Matched Donor Mononuclear Cell-Enriched Leukocytes Apocell Vaccine
|
|
4570
|
PAGR1 |
Homo sapiens |
|
79447
|
|
13375654
|
|
AC009133 |
NP_078792 |
|
|
PAXIP1 associated glutamate rich protein 1 |
Protective antigen |
PA-1-STK Ovarian Carcinoma Vaccine
|
|
1352
|
PAP |
Mus musculus |
|
56318
|
|
46575784
|
|
AC127422 |
NP_062781 |
|
|
transcript variant 1 |
Protective antigen |
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
|
|
1305
|
Pap antigen |
Homo sapiens |
|
55
|
|
6382064
|
|
AC020633 |
NP_001090 |
|
|
transcript variant 2 |
Other |
pTVG-HP Plasmid DNA Vaccine
|
|
4571
|
PAX3 |
Homo sapiens |
|
5077
|
|
6654638
|
|
AC010980 |
NP_000429 |
|
|
transcript variant PAX3I |
Protective antigen |
PAX3/FKHR Peptide Vaccine
|
|
4815
|
PDCD1 |
Homo sapiens |
|
5133
|
|
167857792
|
|
AC131097 |
NP_005009 |
|
|
transcript variant X1 |
Protective antigen |
MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine
|
|
1387
|
Pdgfrb |
Mus musculus |
|
18596
|
|
226342982
|
|
AC124448 |
NP_001139740 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4408
|
PMEL - OBSOLETE |
Homo sapiens |
|
6490
|
|
318037593
|
|
AC025162 |
NP_001186982 |
|
|
transcript variant 3 |
Protective antigen |
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
gp100:280-288(288V) Peptide Vaccine
|
|
4534
|
PMEL - obsolete |
Homo sapiens |
|
6490
|
|
318037593
|
|
AC025162 |
NP_001186982 |
|
|
transcript variant 3 |
Protective antigen |
Synthetic Melanoma-Associated Antigens Vaccine
|
|
1687
|
Pmel17 |
Mus musculus |
|
20431
|
|
31981217
|
|
AC117232 |
NP_068682 |
|
|
transcript variant X1 |
Protective antigen |
Melanoma DNA vaccine VR1012/mPmel17
Mouse gp100 Plasmid DNA Vaccine
|
|
4440
|
pp65 |
Mus musculus |
|
18826
|
|
350606354
|
|
AC129591 |
NP_001234913 |
|
|
transcript variant X5 |
Protective antigen |
PEP-CMV Vaccine
|
|
4646
|
PRAME |
Homo sapiens |
|
23532
|
|
619328985
|
|
AC246793 |
NP_001278644 |
|
|
transcript variant 2 |
Protective antigen |
DNA Vector pPRA-PSM Vaccine
Anti-PRAME Immunotherapeutic GSK2302032A Vaccine
|
|
4655
|
Prn |
Mus musculus |
|
111368
|
|
506326690
|
|
AL833794 |
NP_001265187 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4753
|
PROM1 |
Homo sapiens |
|
8842
|
|
224994189
|
|
AC005598 |
NP_001139319 |
|
|
transcript variant X11 |
Protective antigen |
Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine
CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine
ICT-121 Dendritic Cell Vaccine
|
|
1348
|
Prostate specific antigen |
Mus musculus |
|
53320
|
|
228008369
|
|
AC099606 |
NP_001153178 |
|
|
transcript variant 2 |
Protective antigen |
Prostate cancer DNA vaccine pVax-PSA
Adenovirus-PSA Prostate Cancer Vaccine
|
|
1349
|
Prostate stem cell antigen |
Mus musculus |
|
72373
|
|
21312316
|
|
AC118022 |
NP_082492 |
|
|
prostate stem cell antigen |
Protective antigen |
Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
Prostate cancer DNA vaccine encoding PSCA
Prostate cancer DNA vaccine pmPSCA encoding PSCA
|
|
1303
|
Prostate-specific membrane antigen |
Homo sapiens |
|
2346
|
|
62548858
|
GIG27 |
AC110742 |
NP_001014986 |
|
|
transcript variant 6 |
Protective antigen |
Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA
Prostate cancer DNA vaccine hPSMAt encoding PSMA
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
APC8015F
DNA Vector pPRA-PSM Vaccine
Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine
Recombinant Vaccinia-PSA/PSMA Vaccine
Adenovirus-mediated Human Interleukin-12
|
|
1347
|
Prostate-specific membrane antigen |
Rattus norvegicus |
|
85309
|
|
17105334
|
|
AABR07071938 |
NP_476533 |
|
|
folate hydrolase 1 |
Protective antigen |
Prostate cancer DNA vaccine rPSMAt encoding PSMA
|
|
4532
|
PSMB9 |
Homo sapiens |
|
5698
|
|
4506205
|
|
AL669918 |
NP_002791 |
|
|
proteasome 20S subunit beta 9 |
Protective antigen |
LMP-2:340-349 Peptide Vaccine
LMP-2:419-427 Peptide Vaccine
MVA-EBNA1/LMP2 Vaccine
|
|
4737
|
PTPRC |
Homo sapiens |
|
5788
|
|
392306955
|
|
AF492459 |
NP_001254727 |
|
|
transcript variant 4 |
Protective antigen |
Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
|
|
4771
|
PTTG1 |
Homo sapiens |
|
9232
|
|
538260592
|
|
AB505429 |
NP_001269311 |
|
|
transcript variant 2 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
4512
|
RANBP2 |
Homo sapiens |
|
5903
|
|
150418007
|
|
AC010095 |
NP_006258 |
|
|
transcript variant X1 |
Protective antigen |
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
|
|
4634
|
RHD |
Homo sapiens |
|
6007
|
|
189095266
|
|
AB012623 |
NP_001121163 |
|
|
transcript variant X3 |
Protective antigen |
Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
|
|
4808
|
RNF43 |
Homo sapiens |
|
54894
|
|
770075665
|
|
AC004687 |
NP_001292473 |
|
|
transcript variant 2 |
Protective antigen |
HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
|
|
4762
|
ROPN1 |
Homo sapiens |
|
54763
|
|
960513918
|
|
AC117381 |
NP_001304703 |
|
|
transcript variant 5 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
4680
|
Rpsa |
Mus musculus |
|
16785
|
|
224994260
|
|
AC110091 |
NP_035159 |
|
|
ribosomal protein SA |
Protective antigen |
Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine
|
|
4704
|
RUNX1 |
Homo sapiens |
|
861
|
|
49574546
|
|
AF015262 |
NP_001001890 |
|
|
transcript variant X7 |
Protective antigen |
|
|
1333
|
S |
Hepatitis B virus |
|
|
|
128168861
|
|
|
|
|
CDD:279085 |
hepatitis B surface antigen |
Protective antigen |
Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
|
|
4635
|
S100A6 |
Homo sapiens |
|
6277
|
|
7657532
|
|
AX038700 |
NP_055439 |
|
|
transcript variant X1 |
Protective antigen |
Synthetic Peptides E-PRA And E-PSM Vaccine
|
|
4582
|
S100A9 |
Homo sapiens |
|
6280
|
|
4506773
|
|
A12029 |
NP_002956 |
|
|
S100 calcium binding protein A9 |
Protective antigen |
gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
|
|
295
|
SCFV |
Homo sapiens |
|
652070
|
|
|
|
DQ535056 |
|
|
|
single-chain Fv fragment |
Protective antigen |
|
|
722
|
SCGB2A2 |
Homo sapiens |
|
4250
|
|
4505169
|
|
AF015224 |
NP_002402 |
|
|
transcript variant X1 |
Protective antigen |
|
|
4695
|
SDC1 |
Homo sapiens |
|
6382
|
|
55749480
|
|
AC104792 |
NP_001006947 |
|
|
transcript variant 1 |
Protective antigen |
XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
Autologous Dendritic Cell-Tumor Fusion Vaccine
|
|
4484
|
SDC1-Obsolete |
Homo sapiens |
|
6382
|
|
55749480
|
|
AC104792 |
NP_001006947 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4628
|
sialyl-Tn |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
Sialyl Tn-KLH Vaccine
STn-KLH plus Detox Vaccine
|
|
299
|
SILV |
Homo sapiens |
|
6490
|
|
318037593
|
|
AC025162 |
NP_001186982 |
|
|
transcript variant 3 |
Protective antigen |
|
|
4485
|
SLAMF7 |
Homo sapiens |
|
57823
|
|
543583691
|
|
AL121985 |
NP_001269517 |
|
|
transcript variant 3 |
Protective antigen |
XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
|
|
716
|
SLC5A5 |
Homo sapiens |
|
6528
|
|
4507035
|
|
AB032811 |
NP_000444 |
|
|
transcript variant X1 |
Protective antigen |
Cancer DNA Vaccine MIDGE/hNIS encoding hNIS protein
|
|
4758
|
SOX2 |
Homo sapiens |
|
6657
|
|
28195386
|
|
AC117415 |
NP_003097 |
|
|
SRY-box transcription factor 2 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4785
|
SOX6 |
Homo sapiens |
|
55553
|
|
224967050
|
|
AC009869 |
NP_001139283 |
|
|
transcript variant 5 |
Protective antigen |
HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine
|
|
4761
|
SPA17 |
Homo sapiens |
|
53340
|
|
8394343
|
|
AF334810 |
NP_059121 |
|
|
transcript variant X2 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
4772
|
SPANXB1 |
Homo sapiens |
|
728695
|
|
608601818
|
|
AJ457789 |
NP_115850 |
|
|
SPANX family member B1 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
4626
|
SPBC17D11.03c hypothetical protein |
Schizosaccharomyces pombe |
|
2539635
|
|
19113169
|
SPBC17D11.03c |
CU329671 |
NP_596377 |
|
|
|
Protective antigen |
rMeV- SCD
|
|
4630
|
SPY-1 |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
|
|
4547
|
ST8SIA1 |
Homo sapiens |
|
6489
|
|
751130502
|
|
AC007544 |
NP_001291379 |
|
|
transcript variant 2 |
Protective antigen |
Monoclonal Antibody GD2 Anti-Idiotype Vaccine
|
|
1346
|
Steap1 |
Mus musculus |
|
70358
|
|
254553462
|
UNQ6507/PRO23203 |
AC092404 |
NP_081675 |
|
|
six transmembrane epithelial antigen of the prostate 1 |
Protective antigen |
Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
|
|
4549
|
STEAP1 |
Homo sapiens |
|
26872
|
|
9558759
|
|
AC004969 |
NP_036581 |
|
|
STEAP family member 1 |
Protective antigen |
mRNA-Derived Prostate Cancer Vaccine CV9103
|
|
719
|
Survivin |
Homo sapiens |
|
|
|
2315863
|
|
|
|
1XOX
|
CDD:306999
CDD:237989 |
apoptosis inhibitor survivin |
Protective antigen |
Cancer DNA Vaccine pSURV encoding Survivin
hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
Survivin Antigen Vaccine DPX-Survivac
Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
SVN53-67/M57-KLH Peptide Vaccine
Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
|
|
1336
|
Survivin |
Mus musculus |
|
11799
|
|
59859890
|
RP23-268N22.2 |
AB036741 |
NP_001012273 |
|
|
transcript variant 3 |
Protective antigen |
Melanoma DNA vaccine VR-S8/VR-IL2/AD-S8 encoding survivin
|
|
4736
|
TAF1B |
Homo sapiens |
|
9014
|
|
974987474
|
|
AC010969 |
NP_001305905 |
|
|
transcript variant 2 |
Protective antigen |
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
|
|
4455
|
TARP |
Homo sapiens |
|
445347
|
|
51702236
|
|
AC006033 |
NP_001003799 |
|
|
transcript variant X1 |
Protective antigen |
TARP 29-37-9V Peptide Vaccine
Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
TARP 27-35 Peptide Vaccine
|
|
4676
|
TBXT |
Homo sapiens |
|
6862
|
|
394953947
|
|
AL627443 |
NP_001257413 |
|
|
transcript variant 2 |
Protective antigen |
Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
|
|
705
|
TERT |
Homo sapiens |
|
7015
|
|
301129200
|
|
AB016767 |
NP_001180305 |
|
|
transcript variant 4 |
Protective antigen |
Cancer Subunit GV1001 Protein Vaccine
Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine
Telomerase: 540-548 Peptide Vaccine
UV1 Telomerase Peptide Vaccine
hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
hTERT Vaccine V934/V935
hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
hTERT I540/R572Y/D988Y Multipeptide Vaccine
Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine
Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine
Synthetic hTERT DNA Vaccine INO-1400
Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
Survivin Sur1M2 Peptide Vaccine
|
|
4539
|
TET1 |
Homo sapiens |
|
80312
|
|
156139122
|
|
AL360177 |
NP_085128 |
|
|
transcript variant X10 |
Protective antigen |
MELITAC 12.1 Peptide Vaccine
|
|
4643
|
tetX |
Clostridium tetani E88 |
|
24255210
|
|
499413369
|
CTC_RS14060 |
AF528097 |
WP_011100836 |
|
|
tetanus neurotoxin TetX |
Protective antigen |
|
|
4592
|
TF |
Homo sapiens |
|
7018
|
|
1519313280
|
|
AC080128 |
NP_001054 |
|
|
transcript variant 2 |
Protective antigen |
Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
|
|
4670
|
TGFB2 |
Homo sapiens |
|
7042
|
|
208022653
|
|
AC096638 |
NP_001129071 |
|
|
transcript variant 4 |
Protective antigen |
Belagenpumatucel-L
|
|
1344
|
Th |
Mus musculus |
|
21823
|
|
6678337
|
|
AC012382 |
NP_033403 |
|
|
tyrosine hydroxylase |
Other |
|
|
4566
|
TLR4 |
Homo sapiens |
|
7099
|
|
4507533
|
|
AF177765 |
NP_003257 |
|
|
transcript variant 3 |
Protective antigen |
NY-ESO-1/GLA-SE Vaccine ID-G305AmN
Autologous TriMix-DC Melanoma Vaccine
|
|
4503
|
TLR7 |
Homo sapiens |
|
51284
|
|
7706093
|
|
AC003046 |
NP_057646 |
|
|
toll like receptor 7 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
4576
|
TLR9 |
Homo sapiens |
|
54106
|
|
8394456
|
|
AC097637 |
NP_059138 |
|
|
toll like receptor 9 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
4595
|
TMEM37 |
Homo sapiens |
|
140738
|
|
116325983
|
|
AC013275 |
NP_899063 |
|
|
transcript variant X1 |
Protective antigen |
PR1 Leukemia Peptide Vaccine
|
|
4433
|
TNF |
Homo sapiens |
|
7124
|
|
25952111
|
|
AB088112 |
NP_000585 |
|
|
tumor necrosis factor |
Protective antigen |
Ad CMV I kappaB alpha
Allogeneic Dendritic Cell Vaccine COMBIG-DC
Golnerminogene Pradenovec Vaccine
BCG, Cell Wall Skeleton
|
|
4616
|
tnf-alpha |
Oncorhynchus mykiss |
|
100136034
|
|
185135733
|
|
AJ278085 |
NP_001117829 |
|
|
tumour necrosis factor alpha-like |
Protective antigen |
Recombinant Human Fusion Protein L19TNFalpha Vaccine
|
|
294
|
TNFRSF18 |
Homo sapiens |
|
8784
|
|
4759246
|
|
AL162741 |
NP_004186 |
|
|
transcript variant X1 |
Protective antigen |
Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
|
|
4945
|
TNFSF10 |
Homo sapiens |
|
8743
|
|
300193032
|
|
AC007919 |
NP_001177871 |
|
|
transcript variant 4 |
Protective antigen |
Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine
|
|
4583
|
TNFSF18 |
Homo sapiens |
|
8995
|
|
157419142
|
|
AL031599 |
NP_005083 |
|
|
TNF superfamily member 18 |
Protective antigen |
GITRL RNA-transfected Autologous Dendritic Cell Vaccine
|
|
4807
|
TOMM34 |
Homo sapiens |
|
10953
|
|
21361356
|
|
AL109839 |
NP_006800 |
|
|
transcript variant X2 |
Protective antigen |
HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
|
|
4458
|
TOP2A |
Homo sapiens |
|
7153
|
|
19913406
|
|
AC080112 |
NP_001058 |
|
|
transcript variant X1 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
|
|
4580
|
tox1 |
Corynebacterium diphtheriae PW8 |
|
11716682
|
|
376253302
|
CDPW8_0179 |
CP003216 |
YP_005141761 |
|
|
diphtheria toxin |
Protective antigen |
Haemophilus Influenzae B Vaccine
CTP-37-DT Vaccine
Globo H-DT Vaccine OBI-833
|
|
4692
|
TP53 - delete |
Homo sapiens |
|
7157
|
|
120407068
|
|
AB118156 |
NP_000537 |
|
|
transcript variant 2 |
Protective antigen |
|
|
291
|
TPBG |
Homo sapiens |
|
7162
|
|
262205665
|
|
AJ012159 |
NP_001159864 |
|
|
transcript variant 1 |
Protective antigen |
Recombinant Human Papillomavirus Nonavalent Vaccine
Recombinant Modified Vaccinia Ankara-5T4 Vaccine
|
|
1360
|
TRP-1 |
Mus musculus |
|
22178
|
|
530537244
|
RP23-372M15.1 |
AF087673 |
NP_001268943 |
|
|
transcript variant X1 |
Protective antigen |
Melanoma recombinant vector vaccine rVVmTRP-1 encoding TRP-1
TRP1(0RF3):1-9 Peptide Vaccine
Recombinant Vaccinia-TRP1 Vaccine
|
|
1342
|
TRP-2 |
Homo sapiens |
|
1638
|
|
193788640
|
|
AL139318 |
NP_001123361 |
|
|
transcript variant 3 |
Protective antigen |
Melanoma DNA vaccine hTRP2 encoding TRP-2
Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
TRP-2: 180-188 Peptide Vaccine
SCIB1 DNA vaccine
|
|
709
|
Trp2 |
Mus musculus |
|
104042
|
|
|
|
|
|
|
|
tRNA proline 2 |
Protective antigen |
Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
rMCMV-TRP2
|
|
4673
|
TRPC1 |
Homo sapiens |
|
7220
|
|
353411934
|
|
AC022291 |
NP_001238774 |
|
|
transcript variant X4 |
Protective antigen |
|
|
4529
|
Tumor Associated Antigen |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Vaccine
|
|
1335
|
Tyrosinase |
Homo sapiens |
|
7299
|
|
4507753
|
|
AH003020 |
NP_000363 |
|
|
transcript variant X1 |
Protective antigen |
Melanoma DNA vaccine TA2Mâ„¢ encoding tyrosinase peptides
Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
Tyrosinase-KLH Vaccine
Vaccinia-Tyrosinase Vaccine
Xenogeneic Tyrosinase DNA Vaccine
Alpha-type-1 Polarized Dendritic Cells
Autologous TriMix-DC Melanoma Vaccine
27-35(27L):MART-1 peptide vaccine
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
Recombinant Fowlpox-Tyrosinase Vaccine
Synchrotope TA2M Plasmid DNA Vaccine
Synchrovax SEM Plasmid DNA Vaccine
MELITAC 12.1 Peptide Vaccine
|
|
1377
|
Tyrosinase from Mouse |
Mus musculus |
|
22173
|
|
959092340
|
|
AC122517 |
NP_001304326 |
|
|
transcript variant 2 |
Protective antigen |
Melanoma DNA vaccine xenogeneic DNA encoding murine tyrosinase
|
|
293
|
TYRP1 |
Homo sapiens |
|
7306
|
|
4507757
|
RP11-3L8.1 |
AF001295 |
NP_000541 |
|
CDD:144010
CCDS:CCDS34990.1
HGNC:12450
HPRD:00283
MIM:115501 |
transcript variant X1 |
Protective antigen |
B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
Bcl-Xs Adenovirus Vaccine
|
|
4789
|
Tyrp1 |
Mus musculus |
|
22178
|
|
530537244
|
|
AF087673 |
NP_001268943 |
|
|
transcript variant X1 |
Protective antigen |
B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1
B16 melanoma DNA vaccine pSin-mTRP-1
|
|
1345
|
Ubiquitin |
Mus musculus |
|
|
|
55118
|
|
|
|
|
CDD:176398
GDB:120478
GDB:133775
GOA:P0CG49
InterPro: IPR000626
InterPro: IPR019954
InterPro: IPR019955
InterPro: IPR019956
UniProtKB/UniProt: P0CG49 |
ubiquitin |
Protective antigen |
Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
|
|
4556
|
UL122 |
Human betaherpesvirus 5 |
|
3077563
|
|
52139286
|
HHV5wtgp107 |
AY446894 |
YP_081561 |
|
|
regulatory protein IE2 |
Protective antigen |
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
|
|
4555
|
UL123 |
Human betaherpesvirus 5 |
|
3077513
|
|
52139287
|
HHV5wtgp108 |
AY446894 |
YP_081562 |
|
|
regulatory protein IE1 |
Protective antigen |
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
|
|
4476
|
UL83 |
Human betaherpesvirus 5 |
|
3077579
|
|
52139256
|
HHV5wtgp077 |
AY446894 |
YP_081531 |
|
|
tegument protein pp65 |
Protective antigen |
VCL-CB01 Vaccine
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine
CMVpp65/gB Plasmid Vaccine ASP0113
|
|
4660
|
UL83 |
Human betaherpesvirus 5 |
|
3077579
|
|
52139256
|
HHV5wtgp077 |
AY446894 |
YP_081531 |
|
|
tegument protein pp65 |
Protective antigen |
|
|
4813
|
UL97 |
|
|
|
|
|
|
|
|
|
|
|
|
Adenovirus RSV-TK
|
|
714
|
VEGFA |
Homo sapiens |
|
7422
|
|
76781480
|
RP1-261G23.1 |
AF092126 |
NP_001020537 |
2VPF
|
|
transcript variant 1 |
Protective antigen |
URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
VEGFR-2 DNA Vaccine VXM01
hVEGF26-104/RFASE Peptide Vaccine
LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
PAX3/FKHR Peptide Vaccine
Cancer VEGFA protein vaccine
|
|
4424
|
VHL |
Homo sapiens |
|
7428
|
|
4507891
|
|
AC034193 |
NP_000542 |
|
|
transcript variant 3 |
Protective antigen |
VHL-42: 65-76(V74G) Peptide Vaccine
VHL-59: 116-128 Peptide Vaccine
VHL14 Peptide Vaccine
VHL16 Peptide Vaccine
VHL2 (Y12M) Peptide Vaccine
Von Hippel-Lindau Peptide Vaccine
(H115D)VHL35 Peptide Vaccine
FrSh61 (MEA) VHL33 Peptide Vaccine
|
|
4494
|
WHcAg |
Woodchuck hepatitis virus |
|
2546420
|
|
22256034
|
WhBvgp4 |
J02442 |
NP_671816 |
|
|
core protein |
Protective antigen |
Interferon-gamma-expressing Adenovirus Vaccine ASN-002
|
|
4421
|
WT1 |
Homo sapiens |
|
7490
|
|
1327848674
|
|
AH003034 |
NP_000369 |
|
|
transcript variant H |
Protective antigen |
WT1 124-138 Peptide Vaccine
WT1 126-134 Peptide Vaccine
WT1 247-261 Peptide Vaccine
WT1 Analog Peptide Vaccine
WT1 Peptide Vaccine OCV-501
WT1 Peptide Vaccine WT2725
Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
Allogeneic Cellular Vaccine 1650-G
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine
WT1 235-243 Peptide Vaccine
p.DOM-WT1-126 DNA Vaccine
p.DOM-WT1-37 DNA Vaccine
Recombinant Adenovirus-p53 SCH-58500 Vaccine
Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine
|
|
4483
|
Xbp1 |
Mus musculus |
|
22433
|
|
411147451
|
|
AB036745 |
NP_001258659 |
|
|
transcript variant 1 |
Protective antigen |
XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
|
|
4784
|
XBP1 |
Homo sapiens |
|
7494
|
|
118640873
|
|
CH471095 |
NP_001073007 |
|
|
transcript variant 2 |
Protective antigen |
hTERT/Survivin/CMV Multipeptide Vaccine
|
|
4746
|
Xcl1 |
Mus musculus |
|
16963
|
|
6678712
|
|
AC133891 |
NP_032536 |
|
|
chemokine (C motif) ligand 1 |
Protective antigen |
|
|
4781
|
XCL1 |
Homo sapiens |
|
6375
|
|
4506853
|
|
AL031736 |
NP_002986 |
|
|
transcript variant X1 |
Protective antigen |
Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine
|
|
4757
|
YBX1 |
Homo sapiens |
|
4904
|
|
34098946
|
|
AC098484 |
NP_004550 |
|
|
transcript variant 2 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
